Molina Healthcare, Inc (MOH) Fair Value & Analysis
Healthcare · US · Market cap $10.0B
Molina Healthcare, Inc
MOH · US
Fair value as of: Jun 24, 2026
From 15 valuation models · updated 5 days ago
Fair value updated Jun 24, 2026 — revised from $160.95 to $200.60 (+24.6%) since Jun 23, 2026. Share price +32.2% over the past month.
Price vs Fair Value (12 months)
12‑month range $105.03 – $262.28 · fair‑value band $149.48 – $259.06 · the $196.56 price screens below the $200.60 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Molina Healthcare, Inc (MOH) currently trades at $196.56, while our model-based Fair Value estimate is $200.60 — implying the stock looks roughly 2.1% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, Molina Healthcare, Inc generated revenue of $43.1B at a net margin of 0.4%. Revenue declined 4.3% year over year. It earns a return on equity of 4.5%. The balance sheet holds a net cash position of $298M. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
Molina Healthcare, Inc. provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces in the United States. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company was founded in 1980 and is headquartered in Long Beach, California.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Molina Healthcare, Inc reported revenue of $45.4B in FY2025 versus $27.8B in FY2021, a compound +13.1%/yr. Reported net income was $472M in FY2025, compounding −8.0%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Healthcare Plans stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| UnitedHealth Group UNH | 7,169 MXN | 292.06 MXN | -96% |
| CVS Health Corporation CVS | C$23.81 | C$17.91 | -25% |
| Elevance Health, Inc E1LV34 | R$421.98 | R$340.32 | -19% |
| The Cigna Group CI | $295.81 | $500.99 | +69% |
| Humana Inc HUM | $349.80 | $212.91 | -39% |
| Centene Corporation CNC | $65.34 | $248.86 | +281% |
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Molina Healthcare, Inc (MOH) undervalued?
What is the fair value of MOH?
What is the quality score of MOH?
What is the revenue of Molina Healthcare, Inc (MOH)?
What is the net profit margin of MOH?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.